Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 Beijing SL Pharmaceutical invested PnuVax and entered into high-end vaccine market
CreateTime:2011-09-08     Source:ResearchInChina Editor:hangmei
Text Size:       
Beijing SL Pharmaceutical announced on 13th Aug, that it will invest RMB130 million to set up joint-venture PnuVax SL with Canadian company PnuVax Incorporated. SL Pharmaceutical and PnuVax will ho...
Forget password? get password
Welcome to our website.
This service is open to member only.

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports
China Pharmaceutical Excipients Industry Report, 2014-2017
China Recombinant Protein Drug Industry Report, 2014-2017
China Heparin Industry Report, 2014-2017
Global and China Monoclonal Antibody Industry Report, 2014-2019
Global and China DNA Sequencing Industry Research Report, 2014...
2005-2010 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1